A systematic review of symptom assessment scales in children with cancer

BMC Cancer

L Lee Dupuis³  Marie-Chantal Ethier²  Deborah Tomlinson²  Tanya Hesser²  Lillian Sung¹ 

[1] Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada

[2] Program in Child Health Evaluative Sciences, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada

[3] Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada

关键词: Cancer;    Children;    Scale;    Assessment;    Screening;    Symptom;   

Others  :  1080179
DOI  :  10.1186/1471-2407-12-430

 received in 2012-02-08, accepted in 2012-09-19,  发布年份 2012

【 摘 要 】

Background

The objective was to describe symptom assessment scales that have been used in children with cancer.

Methods

We conducted electronic searches of OVID Medline and EMBASE in order to identify all symptom assessment scales that have been used in pediatric cancer. Two reviewers abstracted information from each identified study. Data collected included study demographics and information related to the instrument and children enrolled. We also collected information about the purpose of instrument administration and whether treatment was altered as a result of this information.

Results

Fourteen studies were identified which evaluated eight different symptom assessment scales. Eight studies used child self-report and all studies included children on active treatment for cancer although 4 studies also included children following completion of treatment. The most common purpose of instrument administration was to measure the prevalence of symptom burden (n = 8). None of the 14 studies used the scale to screen for symptoms and none changed patient management on the basis of identified symptoms.

Conclusions

We failed to identify any symptom assessment scales that were used as a symptom screening tool. There is a need to develop such a tool for use in children with cancer.

【 授权许可】

   
2012 Dupuis et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Baggott C, Dodd M, Kennedy C, Marina N, Matthay KK, Cooper BA, Miaskowski C: Changes in children's reports of symptom occurrence and severity during a course of myelosuppressive chemotherapy. J Pediatr Oncol Nurs 2010, 27(6):307-315.
• [2]Miller E, Jacob E, Hockenberry MJ: Nausea, pain, fatigue, and multiple symptoms in hospitalized children with cancer. Oncol Nurs Forum 2011, 38(5):E382-393.
• [3]Poder U, Ljungman G, von Essen L: Parents' perceptions of their children's cancer-related symptoms during treatment: a prospective, longitudinal study. J Pain Symptom Manage 2010, 40(5):661-670.
• [4]Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, et al.: Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006, 355(15):1572-1582.
• [5]Taddio A, Katz J: The effects of early pain experience in neonates on pain responses in infancy and childhood. Paediatr Drugs 2005, 7(4):245-257.
• [6]Carelle N, Piotto E, Bellanger A, Germanaud J, Thuillier A, Khayat D: Changing patient perceptions of the side effects of cancer chemotherapy. Cancer 2002, 95(1):155-163.
• [7]Coates A, Abraham S, Kaye SB, Sowerbutts T, Frewin C, Fox RM, Tattersall MH: On the receiving end–patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 1983, 19(2):203-208.
• [8]de Boer-Dennert M, de Wit R, Schmitz PI, Djontono J, v Beurden V, Stoter G, Verweij J: Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists. Br J Cancer 1997, 76(8):1055-1061.
• [9]Griffin AM, Butow PN, Coates AS, Childs AM, Ellis PM, Dunn SM, Tattersall MH: On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 1996, 7(2):189-195.
• [10]Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K: The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 1991, 7(2):6-9.
• [11]Ontario Cancer Symptom Management Collaborative. https://www.cancercare.on.ca/cms/one.aspx?portalId=1377&pageId=57595 webcite
• [12]World Health Organization: World Health Organization Constitution. World Health Organization, Geneva; 1948.
• [13]von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008, 61(4):344-349.
• [14]Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
• [15]Hayden JA, Cote P, Bombardier C: Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006, 144(6):427-437.
• [16]Gibson F, Aldiss S, Taylor RM, Maguire R, McCann L, Sage M, Kearney N: Utilization of the Medical Research Council evaluation framework in the development of technology for symptom management: the ASyMS-YG Study. Cancer Nurs 2010, 33(5):343-352.
• [17]Dupuis LL, Milne-Wren C, Cassidy M, Barrera M, Portwine C, Johnston DL, Silva MP, Sibbald C, Leaker M, Routh S, et al.: Symptom assessment in children receiving cancer therapy: the parents' perspective. Support Care Cancer 2010, 18(3):281-299.
• [18]Baggott CR, Dodd M, Kennedy C, Marina N, Matthay KK, Cooper B, Miaskowski C: An evaluation of the factors that affect the health-related quality of life of children following myelosuppressive chemotherapy. Support Care Cancer 2011, 19(3):353-361.
• [19]Wu WW, Johnson R, Schepp KG, Berry DL: Electronic self-report symptom and quality of life for adolescent patients with cancer: a feasibility study. Cancer Nurs 2011, 34(6):479-486.
• [20]Walker AJ, Gedaly-Duff V, Miaskowski C, Nail L: Differences in symptom occurrence, frequency, intensity, and distress in adolescents prior to and one week after the administration of chemotherapy. J Pediatr Oncol Nurs 2010, 27(5):259-265.
• [21]Sitaresmi MN, Mostert S, Purwanto I, Gundy CM, Sutaryo , Veerman AJ: Chemotherapy-related side effects in childhood acute lymphoblastic leukemia in Indonesia: parental perceptions. J Pediatr Oncol Nurs 2009, 26(4):198-207.
• [22]Yeh CH, Wang CH, Chiang YC, Lin L, Chien LC: Assessment of symptoms reported by 10- to 18-year-old cancer patients in Taiwan. J Pain Symptom Manage 2009, 38(5):738-746.
• [23]Williams PD, Schmideskamp J, Ridder EL, Williams AR: Symptom monitoring and dependent care during cancer treatment in children: pilot study. Cancer Nurs 2006, 29(3):188-197.
• [24]Collins JJ, Devine TD, Dick GS, Johnson EA, Kilham HA, Pinkerton CR, Stevens MM, Thaler HT, Portenoy RK: The measurement of symptoms in young children with cancer: the validation of the Memorial Symptom Assessment Scale in children aged 7–12. J Pain Symptom Manage 2002, 23(1):10-16.
• [25]Hinds PS, Schum L, Srivastava DK: Is clinical relevance sometimes lost in summative scores? West J Nurs Res 2002, 24(4):345-353.
• [26]Collins JJ, Byrnes ME, Dunkel IJ, Lapin J, Nadel T, Thaler HT, Polyak T, Rapkin B, Portenoy RK: The measurement of symptoms in children with cancer. J Pain Symptom Manage 2000, 19(5):363-377.
• [27]Berard RM, Boermeester F: Psychiatric symptomatology in adolescents with cancer. Pediatr Hematol Oncol 1998, 15(3):211-221.
• [28]Eiser C, Havermans T, Craft A, Kernahan J: Validity of the Rotterdam symptom checklist in paediatric oncology. Med Pediatr Oncol 1997, 28(6):451-454.
• [29]de Haes JCJM, Olschewski M, Fayers P, Visser MRM, Cull A, Hopwood P, Sanderman R: The Rotterdam Symptom Checklist: A manual. Northern Centre for Healthcare Research (NCH), University of Groningen, The Netherlands; 1996.
• [30]Woodgate RL: Children's cancer symptom experiences: keeping the spirit alive in children and their families… The 2002 Schering Lecture, 14th Annual CANO Conference – sponsored by Schering Canada. Can Oncol Nurs J 2003, 13(3):142-150.